首页> 外文期刊>National Journal of Medical Research >Prospective Evaluation of Migration, Complications and Utility of Fiducial Placement for CyberKnife Treatment in Hepatobiliary Tumors
【24h】

Prospective Evaluation of Migration, Complications and Utility of Fiducial Placement for CyberKnife Treatment in Hepatobiliary Tumors

机译:肝脏肿瘤中杂志治疗基准安置的迁移,并发症和效用的前瞻性评价

获取原文
           

摘要

"Background: Hepatocellular carcinoma (HCC) is the most common primary tumor of the hepatobiliary system. The Cyberknife represents a new, frameless stereotactic radiosurgery system with image-guided radiation delivery using fiducials as markers to overcome the movement of intra-abdominal organs due to respiration. However fiducial placement and treatment have its issues such as migration and other complications. Objectives: We evaluated the accuracy and feasibility of fiducial placement under image guidance and complications during and after placement such as migration including pain score. Materials and Methods: A prospective observational study was carried out on 36 subjects with clinically and radiologically diagnosed hepatocellular carcinoma receiving Cyberknife based stereotactic based radiotherapy (SBRT). Fiducial markers for SBRT were introduced under percutaneous Ultrasound (US) or CT guidance. After placement, fiducial migration rate, pain score, fiducial placement related complications were noted during and after therapy. IBM SPSS statistical software version 21 was used for statistical analysis. Results: 8.4% had gross fiducial displacement on the day of the procedure. 90.9% had minimal migration during treatment.There was no gross migration seen during treatment or post-treatment. Post fiducial placement, 2.8 % had a major complication in the form of liver decompensation resulting in death while minor complications were observed in 13.9%. The average pain score was minimal (0.86) post fiducial placement. There was no pain in any of the patients during or after the treatment. Conclusion: Image-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy had a high technical success rate and is a safe procedure with rare complications.There is minimal fiducial migration seen during the treatment. But being a descriptive study with a small sample size limits the generalizability of our study findings.
机译:“背景:肝细胞癌(HCC)是肝胆道系统中最常见的原发性肿瘤。Cyber​​ Knife代表了一种新的无框架立体定向放射外科术系统,具有使用基准的图像引导辐射递送作为标记,以克服由于腹部内器官的运动呼吸。然而,基准安置和治疗有迁移和其他并发症等问题。目标:我们评估了在图像指导和安置期间和在包括疼痛评分等迁移期间和后的复杂性的基准放置的准确性和可行性。材料和方法:材料和方法:一种预期在36项受试者中进行了观察性研究,临床和放射学诊断肝细胞癌接受克星基于立体定向的放射治疗(SBRT)。在经皮超声(US)或CT指导下引入了SBRT的基准标记。放置后,基准迁移率,疼痛评分,基准安置相关的CO在治疗期间和疗法期间注意到了互动。 IBM SPSS统计软件版本21用于统计分析。结果:8.4%在程序的当天有严格的排量。治疗期间,90.9%的迁移最小。治疗或治疗后没有看到总迁移。后基准展示位置,2.8%的肝脏代理形式具有主要并发症,导致死亡,同时观察到13.9%的轻微并发症。平均疼痛评分最小(0.86)后基准放置。治疗期间或之后的任何患者都没有疼痛。结论:肝脏肝脏肝脏基准标记的图像引导植入具有高的技术成功率,并且是一种罕见并发症的安全程序。在治疗过程中看到最小的基准迁移。但是作为具有小样本大小的描述性研究限制了我们研究结果的概括性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号